CASI Pharmaceuticals
CASI
CASI
20 hedge funds and large institutions have $8.14M invested in CASI Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
75% less call options, than puts
Call options by funds: $2K | Put options by funds: $8K
Holders
20
Holding in Top 10
–
Calls
$2K
Puts
$8K
Top Buyers
| 1 | +$5.39M | |
| 2 | +$349K | |
| 3 | +$188K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$135K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$20.7K |
Top Sellers
| 1 | -$82.9K | |
| 2 | -$17K | |
| 3 | -$5K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$550 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$154 |